Suggestions
Keith Hoffman, PhD
Chief Business Officer at Athos Therapeutics Inc
Keith Bronson Hoffman, PhD, is the Chief Business Officer at Athos Therapeutics Inc., a biotechnology company focused on developing precision therapeutics for autoimmune diseases and cancer. He joined Athos on November 2, 2020, where he is responsible for overseeing business development, funding, and partnerships. Dr. Hoffman reports directly to the CEO, Dimitrios Iliopoulos, and plays a crucial role in advancing the company's innovative drug development initiatives, particularly for conditions like Inflammatory Bowel Diseases, systemic lupus erythematosus, and psoriasis.12
Before his role at Athos, Dr. Hoffman served as the Senior Vice President of Business Development and Technology Transfer at the Lundquist Institute for Biomedical Innovation. There, he managed commercialization efforts, licensing, and the formation of startup companies. His previous experience includes being part of the founding team at Advera Health Analytics, where he developed big data platforms, and holding senior management positions in various biotechnology and healthcare companies.123
Dr. Hoffman holds a BS in Biology and a PhD in Neuropharmacology from the University of California, Irvine, where he researched the molecular basis of learning and memory. He has an extensive publication record, including 30 academic papers and over 70 patent applications.12
